Constellium Se Financials
This page shows Constellium Se (CSTM) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores
Constellium Se's revenue declined 6.3% year-over-year, from $7.8B to $7.3B. This contraction results in a growth score of 11/100.
Constellium Se has elevated debt relative to equity (D/E of 2.66), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 13/100, reflecting increased financial risk.
Constellium Se's current ratio of 1.27 indicates adequate short-term liquidity, earning a score of 31/100. The company can meet its near-term obligations, though with limited headroom.
While Constellium Se generated $301.0M in operating cash flow, capex of $413.0M consumed most of it, leaving -$112.0M in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.
Constellium Se's ROE of 7.9% shows moderate profitability relative to equity, earning a score of 32/100. This is down from 21.2% the prior year.
Constellium Se passes 4 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, Constellium Se generates $5.38 in operating cash flow ($301.0M OCF vs $56.0M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Key Financial Metrics
Constellium Se generated $7.3B in revenue in fiscal year 2024. This represents a decrease of 6.3% from the prior year.
Constellium Se generated -$112.0M in free cash flow in fiscal year 2024, representing cash available after capex. This represents a decrease of 269.7% from the prior year.
Constellium Se reported $56.0M in net income in fiscal year 2024. This represents a decrease of 63.2% from the prior year.
Constellium Se earned $0.38 per diluted share (EPS) in fiscal year 2024. This represents a decrease of 63.1% from the prior year.
Constellium Se held $141.0M in cash against $1.9B in long-term debt as of fiscal year 2024.
Constellium Se had 144M shares outstanding in fiscal year 2024. This represents a decrease of 2.2% from the prior year.
Constellium Se's gross margin was 12.8% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is down 0.7 percentage points from the prior year.
Constellium Se's net profit margin was 0.8% in fiscal year 2024, showing the share of revenue converted to profit. This is down 1.2 percentage points from the prior year.
Constellium Se's ROE was 7.9% in fiscal year 2024, measuring profit generated per dollar of shareholder equity. This is down 13.2 percentage points from the prior year.
Constellium Se invested $49.0M in research and development in fiscal year 2024. This represents a decrease of 5.8% from the prior year.
Constellium Se spent $79.0M on share buybacks in fiscal year 2024, returning capital to shareholders by reducing shares outstanding.
Constellium Se invested $413.0M in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents an increase of 12.8% from the prior year.
CSTM Income Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|
| Revenue | $2.2B+3.0% | $2.1B+6.3% | $2.0B+15.0% | $1.7B-10.9% | $1.9B+2.8% | $1.9B | N/A |
| Cost of Revenue | $1.9B+0.7% | $1.8B+7.2% | $1.7B+13.4% | $1.5B-8.4% | $1.7B+1.0% | $1.6B | N/A |
| Gross Profit | $314.0M+19.4% | $263.0M0.0% | $263.0M+26.4% | $208.0M-25.7% | $280.0M+14.3% | $245.0M | N/A |
| R&D Expenses | $12.0M0.0% | $12.0M-7.7% | $13.0M+30.0% | $10.0M-23.1% | $13.0M-13.3% | $15.0M | N/A |
| SG&A Expenses | $85.0M-3.4% | $88.0M+12.8% | $78.0M-15.2% | $92.0M+22.7% | $75.0M-6.3% | $80.0M | N/A |
| Operating Income | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Interest Expense | $27.0M+8.0% | $25.0M0.0% | $25.0M-7.4% | $27.0M+22.7% | $22.0M-12.0% | $25.0M | N/A |
| Income Tax | $38.0M+90.0% | $20.0M-16.7% | $24.0M-17.2% | $29.0M+7.4% | $27.0M+237.5% | $8.0M | N/A |
| Net Income | $88.0M+144.4% | $36.0M-2.7% | $37.0M+177.1% | -$48.0M-163.2% | $76.0M+261.9% | $21.0M | N/A |
| EPS (Diluted) | $0.62+148.0% | $0.25-3.8% | $0.26+181.3% | $-0.32-162.7% | $0.51+264.3% | $0.14 | N/A |
CSTM Balance Sheet
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|
| Total Assets | $5.4B+0.1% | $5.4B+3.9% | $5.2B+9.2% | $4.7B | N/A | N/A | $4.9B |
| Current Assets | $2.4B+1.8% | $2.3B+3.4% | $2.2B+21.9% | $1.8B | N/A | N/A | $2.0B |
| Cash & Equivalents | $122.0M-8.3% | $133.0M+12.7% | $118.0M-16.3% | $141.0M-38.2% | $228.0M+17.5% | $194.0M-13.0% | $223.0M |
| Inventory | $1.4B+2.9% | $1.3B+3.9% | $1.3B+8.2% | $1.2B | N/A | N/A | $1.2B |
| Accounts Receivable | $693.0M+2.1% | $679.0M+2.1% | $665.0M+74.5% | $381.0M | N/A | N/A | $418.0M |
| Goodwill | $47.0M0.0% | $47.0M+2.2% | $46.0M0.0% | $46.0M | N/A | N/A | $41.0M |
| Total Liabilities | $4.5B-1.2% | $4.6B+3.8% | $4.4B+9.9% | $4.0B | N/A | N/A | $4.2B |
| Current Liabilities | $1.8B-1.7% | $1.9B+3.6% | $1.8B+25.0% | $1.4B | N/A | N/A | $1.6B |
| Long-Term Debt | $2.0B+0.1% | $2.0B+3.4% | $1.9B+1.5% | $1.9B | N/A | N/A | $1.9B |
| Total Equity | $845.0M+8.3% | $780.0M+4.7% | $745.0M+5.5% | $706.0M-11.3% | $796.0M+6.0% | $751.0M+4.6% | $718.0M |
| Retained Earnings | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
CSTM Cash Flow Statement
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $99.0M-13.2% | $114.0M+96.6% | $58.0M-4.9% | $61.0M-55.8% | $138.0M+273.0% | $37.0M | N/A |
| Capital Expenditures | $75.0M-2.6% | $77.0M+11.6% | $69.0M-54.3% | $151.0M+79.8% | $84.0M+13.5% | $74.0M | N/A |
| Free Cash Flow | $24.0M-35.1% | $37.0M+436.4% | -$11.0M+87.8% | -$90.0M-266.7% | $54.0M+245.9% | -$37.0M | N/A |
| Investing Cash Flow | -$69.0M+4.2% | -$72.0M-22.0% | -$59.0M+52.8% | -$125.0M-104.9% | -$61.0M-22.0% | -$50.0M | N/A |
| Financing Cash Flow | -$41.0M-13.9% | -$36.0M-38.5% | -$26.0M-157.8% | $45.0M+209.8% | -$41.0M-310.0% | -$10.0M | N/A |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | $25.0M-28.6% | $35.0M+133.3% | $15.0M-21.1% | $19.0M-40.6% | $32.0M+357.1% | $7.0M | N/A |
CSTM Financial Ratios
| Metric | Q3'25 | Q2'25 | Q1'25 | Q3'24 | Q2'24 | Q1'24 | Q4'23 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 14.5%+2.0pp | 12.5%-0.8pp | 13.3%+1.2pp | 12.1%-2.4pp | 14.5%+1.5pp | 13.0% | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | 4.1%+2.3pp | 1.7%-0.2pp | 1.9%+4.7pp | -2.8%-6.7pp | 3.9%+2.8pp | 1.1% | N/A |
| Return on Equity | 10.4%+5.8pp | 4.6%-0.4pp | 5.0%+4.1pp | 0.9%-8.7pp | 9.6%+6.8pp | 2.8% | N/A |
| Return on Assets | 1.6%+1.0pp | 0.7%-0.0pp | 0.7%+1.7pp | -1.0% | N/A | N/A | N/A |
| Current Ratio | 1.28+0.0 | 1.230.0 | 1.24-0.0 | 1.27 | N/A | N/A | 1.28 |
| Debt-to-Equity | 2.34-0.2 | 2.53-0.0 | 2.56-0.1 | 2.66 | N/A | N/A | 2.63 |
| FCF Margin | 1.1%-0.7pp | 1.8%+2.3pp | -0.6%+4.7pp | -5.2%-8.0pp | 2.8%+4.8pp | -2.0% | N/A |
Similar Companies
Frequently Asked Questions
What is Constellium Se's annual revenue?
Constellium Se (CSTM) reported $7.3B in total revenue for fiscal year 2024. This represents a -6.3% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Constellium Se's revenue growing?
Constellium Se (CSTM) revenue declined by 6.3% year-over-year, from $7.8B to $7.3B in fiscal year 2024.
Is Constellium Se profitable?
Yes, Constellium Se (CSTM) reported a net income of $56.0M in fiscal year 2024, with a net profit margin of 0.8%.
What is Constellium Se's earnings per share (EPS)?
Constellium Se (CSTM) reported diluted earnings per share of $0.38 for fiscal year 2024. This represents a -63.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
How much debt does Constellium Se have?
As of fiscal year 2024, Constellium Se (CSTM) had $141.0M in cash and equivalents against $1.9B in long-term debt.
What is Constellium Se's gross margin?
Constellium Se (CSTM) had a gross margin of 12.8% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.
What is Constellium Se's net profit margin?
Constellium Se (CSTM) had a net profit margin of 0.8% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.
What is Constellium Se's return on equity (ROE)?
Constellium Se (CSTM) has a return on equity of 7.9% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.
What is Constellium Se's free cash flow?
Constellium Se (CSTM) generated -$112.0M in free cash flow during fiscal year 2024. This represents a -269.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Constellium Se's operating cash flow?
Constellium Se (CSTM) generated $301.0M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
What are Constellium Se's total assets?
Constellium Se (CSTM) had $4.7B in total assets as of fiscal year 2024, including both current and long-term assets.
What are Constellium Se's capital expenditures?
Constellium Se (CSTM) invested $413.0M in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.
How much does Constellium Se spend on research and development?
Constellium Se (CSTM) invested $49.0M in research and development during fiscal year 2024.
Does Constellium Se buy back shares?
Yes, Constellium Se (CSTM) spent $79.0M on share buybacks during fiscal year 2024, returning capital to shareholders by reducing shares outstanding.
How many shares does Constellium Se have outstanding?
Constellium Se (CSTM) had 144M shares outstanding as of fiscal year 2024.
What is Constellium Se's current ratio?
Constellium Se (CSTM) had a current ratio of 1.27 as of fiscal year 2024, which is considered adequate.
What is Constellium Se's debt-to-equity ratio?
Constellium Se (CSTM) had a debt-to-equity ratio of 2.66 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Constellium Se's return on assets (ROA)?
Constellium Se (CSTM) had a return on assets of 1.2% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
What is Constellium Se's Piotroski F-Score?
Constellium Se (CSTM) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Constellium Se's earnings high quality?
Constellium Se (CSTM) has an earnings quality ratio of 5.38x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
How financially healthy is Constellium Se?
Constellium Se (CSTM) scores 17 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.